Cord Blood Stem Cells Information - Cord Blood Stem Cells News

Cord Blood Stem Cells News

Hearing restoration may be possible with cochlear repair after transplant of human cord blood cells Wednesday, September 3, 2008 @ 10:40AMAccording to an Italian research team publishing their findings in the current issue of Cell Transplantation (17:6), hearing loss due to cochlear damage may be repaired by transplantation of human umbilical cord hematopoietic stem cells (HSC) since they show that a small number migrated to the damaged cochlea and repaired sensory hair cells and neurons.
Hearing restoration may be possible with cochlear repair after transplant of human cord blood cells Wednesday, September 3, 2008 @ 10:09AM( Cell Transplantation Center of Excellence for Aging and Brain Repair ) Hearing loss due to cochlear damage may be repaired by transplanting human umbilical cord hematopoietic stem cells. This study, using animal models of chemical and auditory cochlear damage, found that when transplanted stem cells migrated to the damaged area, "surprisingly few" transplanted cells were necessary to help ...
Cryo-Cell International, Inc. to Present at Wall Street Analyst Forum Wednesday, September 3, 2008 @ 7:30AM Cryo-Cell International, Inc. , one of the largest and most established family cord blood banks in the nation, today announced that Mercedes Walton, Chief Executive Officer will speak at the Wall Street Analyst Forum on Tuesday, September 9, at 9:10 a.m.
Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) Wednesday, September 3, 2008 @ 6:00AM Sangamo BioSciences, Inc. announced today that it has opened a Phase 2 clinical trial to evaluate its drug, SB-509, in subjects with ALS, a progressive, degenerative motor-neuron disease for which there are limited treatment options and no cure.
Praying for a miracle Wednesday, September 3, 2008 @ 3:41AMLucas and baby Owen suffer from a rare blood disorder. Their parents are hoping for an equally rare match from a bone marrow donor needed to save their lives.
JCI online early table of contents: Sept. 2, 2008 Tuesday, September 2, 2008 @ 4:27PM( Journal of Clinical Investigation ) This release contains summaries, links to PDFs and contact information for the following newsworthy papers to be published online, Sept. 2, 2008, in the JCI, including: With or without you: premature ageing whether or not protein is modified; Stem cell transplantation benefits mice with childhood motor neuron disease; How to spot a heart attack soon after it ...
Treating Sickle Cell Disease Thursday, August 28, 2008 @ 5:30PMWhile there is not yet a viable, widely available cure for SCD, there are ways to help prevent and treat symptoms and complications. These include:
Clinical-Scale Generation Of Functional Red Blood Cells From Human Embryonic Stem Cells Thursday, August 21, 2008 @ 9:13AMAdvanced Cell Technology, Inc. ("ACT") (OTC: ACTC.PK) reported that it is feasible to differentiate and mature human embryonic stem cells (hESCs) into functional oxygen-carrying red blood cells (RBCs) under conditions suitable for scale-up.
New York Stem Cell Foundation announces third annual Translational Stem Cell Research Conference Thursday, August 21, 2008 @ 8:42AM( New York Stem Cell Foundation ) The New York Stem Cell Foundation will hold its third annual Translational Stem Cell Research Conference Oct. 14-15 in New York City.
Health Highlights: Aug. 20, 2008 Wednesday, August 20, 2008 @ 11:01AM Here are some of the latest health and medical news developments, compiled by editors of HealthDay:
Cord Blood America Reports Six Month Financial Results Wednesday, August 20, 2008 @ 4:00AM Cord Blood America, Inc. , the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today reported that revenues for the first six months of 2008, ended June 30, totaled $2.4 million.
Clinical-Scale Generation of Functional Red Blood Cells from Human Embryonic Stem Cells Tuesday, August 19, 2008 @ 2:30PMAdvanced Cell Technology, Inc. ("ACT") (OTC: ACTC.PK) reported that it is feasible to differentiate and mature human embryonic stem cells (hESCs) into functional oxygen-carrying red blood cells (RBCs) under conditions suitable for scale-up. The research, which appears online (pre-published ahead of print) in the journal Blood -the leading publication in the field --by ACTC and its collaborators ...
Clinical-Scale Generation of Functional Red Blood Cells from Human Embryonic Stem Cells Tuesday, August 19, 2008 @ 2:14PMAdvanced Cell Technology, Inc. ("ACT") (OTC: ACTC.PK) reported that it is feasible to differentiate
Gladstone Scientists Identify Single MicroRNA That Controls Blood Vessel Development Wednesday, August 13, 2008 @ 4:12AMScientists from the Gladstone Institute of Cardiovascular Disease (GICD) and UCSF have identified a key regulatory factor that controls development of the human vascular system, the extensive network of arteries, veins, and capillaries that allow blood to reach all tissues and organs.
Single MicroRNA That Controls Blood Vessel Development Identified Wednesday, August 13, 2008 @ 12:24AMScientists have identified a key regulatory factor that controls development of the human vascular system, the extensive network of arteries, veins and capillaries that allow blood to reach all tissues and organs.
Geron and Exeter Life Sciences Merge Start Licensing and ViaGen to Form Combined Licensing and Operating Company for ... Tuesday, August 12, 2008 @ 6:54AMGeron Corporation (Nasdaq:GERN) and Exeter Life Sciences, Inc. announced today the merger of Start Licensing, Inc. ("Start"), a joint venture between Geron and Exeter Life Sciences, and ViaGen, Inc., a subsidiary of Exeter Life Sciences.
Americans travel overseas for stem-cell treatment Sunday, July 20, 2008 @ 1:12AMPHILADELPHIA: In February, Marcela DeVivo took her baby son to the Dominican Republic and paid $30,000 to have him injected with blood stem cells from aborted fetuses.
Gamida Cell in Cordis unit collaboration Monday, July 14, 2008 @ 12:19PMBiologics Delivery Systems will supply catheters for the upcoming Phase I/II clinical trial of Gamida Cell’s CardioCure for post-heart attack treatment.
Cytori Sells First European Union StemSource(R) Bank; Industry Leading Biohellenika of Greece Acquires Exclusive Rights Monday, July 14, 2008 @ 9:51AM SAN DIEGO & ATHENS, Greece----Cytori sold its first European Union StemSource® Cell Bank as part of an agreement with Biohellenika . Biohellenika, the leading provider of cord blood stem cell banking services in Greece, will be the exclusive provider of the StemSource Cell Bank cryopreservation services in Greece, which is one of the largest markets for cell banking in Europe.
ThermoGenesis Announces FDA Authorization to Market MarrowXpress(TM) (MXP(TM)) Monday, July 14, 2008 @ 8:00AM ThermoGenesis Corp. , a leading supplier of innovative products and services that process and store adult stem cells, today said it has received authorization from the FDA to begin marketing its MarrowXpress device for use in a clinical laboratory setting or intraoperatively for preparation of a cell concentrate from bone marrow.
Umbilical Cord Stem Cells Transport Anti-Cancer Drugs Directly to Tumors Thursday, July 10, 2008 @ 12:16PMKansas State University researchers are working on a method of delivering cancer drugs that promises to be more efficient and reduce the side effects patients have to deal with.
Human Embryonic Stem Cells Developed From Four-cell Embryo; World First May Lessen Ethical Concerns Wednesday, July 9, 2008 @ 8:21AMFor the first time in the world scientists have succeeded in developing human embryonic stem cells from a single cell, or blastomere, of a 4-cell stage embryo. The scientists said that their research meant that it might be possible in the future to produce hESC lines at an earlier stage without destroying the embryo.
Global Med Technologies(R) Announces U.S. Release of Proven Tissue and Cellular Therapy Product Tuesday, July 8, 2008 @ 8:00AM Global Med Technologies®, Inc. , an international e-Health, medical information technology company, today announced the immediate release in the United States of EdgeCell, a proven cellular therapy software solution for tissue banks, stem cell laboratories and cord blood banks.
PerkinElmer opens center to research stem cells from umbilical cords Thursday, July 3, 2008 @ 11:45AMPerkinElmer Inc. has created a center dedicated to researching the potential uses of stem cells taken from umbilical cords, the company said Thursday. (PKI)
PerkinElmer Establishes ViaCord Research Institute To Further Cord Blood Stem Cell Advancements Thursday, July 3, 2008 @ 9:34AMPerkinElmer, Inc., a global leader in Health Sciences and Photonics, today announced the creation of the ViaCord Research InstituteT (VRIT) aimed at investigating new potential future uses of umbilical cord blood-derived stem cells
PerkinElmer Establishes ViaCord Research Institute(TM) to Further Cord Blood Stem Cell Advancements Thursday, July 3, 2008 @ 8:45AMPerkinElmer, Inc., a global leader in Health Sciences and Photonics, today announced the creation of the ViaCord Research Institute(TM) (VRI(TM)) aimed at investigating new potential future uses of umbilical cord blood-derived stem cells. Led by a team of leading scientists and physicians, VRI will focus on supporting science, technology and medical treatments using cord blood stem cells in five ...
PerkinElmer Establishes ViaCord Research Institute(TM) to Further Cord Blood Stem Cell Advancements Thursday, July 3, 2008 @ 8:23AM WALTHAM, Mass.----PerkinElmer, Inc., a global leader in Health Sciences and Photonics, today announced the creation of the ViaCord Research Institute™ aimed at investigating new potential future uses of umbilical cord blood-derived stem cells.
Genzyme Files Applications for Approval of Mozobil in the United States and Europe Tuesday, June 17, 2008 @ 8:49AMCAMBRIDGE, Mass. ( Map ) - CAMBRIDGE, Mass. , June 17 /PRNewswire-FirstCall/ -- Genzyme Corporation (Nasdaq: GENZ ) announced today that it has submitted marketing applications in both the United States and the European Union for Mozobil(TM) (plerixafor), a product candidate intended to enhance mobilization of hematopoietic stem cells for collection and subsequent autologous transplantation in ...
Genzyme Files Applications for Approval of Mozobil in the United States and Europe Tuesday, June 17, 2008 @ 7:29AM Genzyme Corporation announced today that it has submitted marketing applications in both the United States and the European Union for Mozobil , a product candidate intended to enhance mobilization of hematopoietic stem cells for collection and subsequent autologous transplantation in patients with lymphoma and multiple myeloma.
Catholic bishops condemn embryonic stem cell research Friday, June 13, 2008 @ 2:37PMU.S. Roman Catholic bishops issued a document Friday warning against what they consider the moral dangers of embryonic stem cell research, saying it treats human beings as commodities and reduces procreation to a manufacturing process.
Umbilical Cord Blood Saves Life of Woman With Cancer Friday, June 13, 2008 @ 11:57AMWhen Suzanne Penney was diagnosed with leukemia after she battled breast cancer, she decided to undergo an injection of umbilical stem cells – and the procedure saved her life, KNSD-TV reported Thursday.
A case reopened as murder Thursday, June 12, 2008 @ 2:10AMMatthew R. Nagle was stabbed in the neck on July 3, 2001, and spent the last six years of his life in a wheelchair. After he died last July, prosecutors said they would consider pressing murder charges against his attacker.
Woman Credits Rare Procedure For Cancer Remission Wednesday, June 11, 2008 @ 10:46PMA Carlsbad woman survives cancer -- twice -- and is crediting a rare stem cell procedure for helping her battle the disease.
Cord blood aids boy with skin disease Tuesday, June 3, 2008 @ 12:21AMAt 2 years old, bright-eyed Nate Liao can finally wear a T-shirt. It may not sound like much, but eight months ago, the fabric would have caused his fragile skin to blister and rub off entirely.
BioE partners with software company Thursday, May 29, 2008 @ 9:25AMBioE Inc., a biomedical startup company that has made headlines for its work in deriving stem cells from human umbilical cord blood, will partner with StemSoft Software Inc., to offer cord-blood banks comprehensive cord-blood data management and cord-blood processing.
National Stem Cell Holding, Inc. Announces the Change of Its Name to Proteonomix, Inc. Wednesday, May 28, 2008 @ 8:30AM National Stem Cell Holding, Inc. today announced that it is taking steps to change its name to Proteonomix, Inc. The change will also entail a change in its trading symbol.
StemSoft and BioE to Offer Quality-Driven, Turnkey Solution for Cord Blood Data Management and Processing Wednesday, May 28, 2008 @ 7:01AMStemSoft Software Inc. and BioE(R), Inc. announced today they have entered into a partnership to provide cord blood banks a complete, quality-driven turnkey solution for comprehensive cord blood data management and cord blood processing.
Washington DC Tuesday, May 27, 2008 @ 9:27AMLOS ANGELES , May 27 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI ), the umbilical cord blood stem cell preservation company ( http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells to families nationwide and internationally, today reported that CorCell Companies Inc., Philadelphia, Pa. , which it acquired in October 2006 ...
Cord Blood America Reports CorCell, Its Major Acquisition in 2006, Turns Profitable Tuesday, May 27, 2008 @ 4:00AM Cord Blood America, Inc. , the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today reported that CorCell Companies Inc., Philadelphia, Pa., which it acquired in October 2006, had its first operationally profitable quarter ever for the three months ending March 31, 2008.
By Susan Guynn News-Post Staff Tuesday, May 27, 2008 @ 1:05AMAt age 6 months, Jordan Lehman could do all those things boys his age like to do. He could sit up, hold his bottle, munch on Cheerios and play with trucks. He laughed and smiled easily.
FDA delays embryonic stem cell trials Wednesday, May 21, 2008 @ 3:40PMWASHINGTON (BP)--The U.S. Food and Drug Administration has put a hold on proposed clinical trials using embryonic stem cells in human beings. The news was a blow to the hopes of the Geron Corp., which had applied for FDA approval for the first such experiments.
ImmunoCellular Therapeutics Announces Completion of Proof-of-Principle Studies Demonstrating Efficacy of Cancer Stem ... Wednesday, May 21, 2008 @ 8:31AMImmunoCellular Therapeutics, Ltd. (OTC:IMUC) (IMUC), a biotechnology company, today announced that recently completed proof-of-principle studies demonstrate efficacy of its cancer stem cell vaccine technology in treating glioblastoma, a form of brain cancer, in preclinical animal models. The company is planning to submit an Investigational New Drug (IND) application to the FDA later this year to ...
ImmunoCellular Therapeutics Announces Completion of Proof-of-Principle Studies Demonstrating Efficacy of Cancer Stem ... Wednesday, May 21, 2008 @ 8:00AM LOS ANGELES----ImmunoCellular Therapeutics, Ltd. , a biotechnology company, today announced that recently completed proof-of-principle studies demonstrate efficacy of its cancer stem cell vaccine technology in treating glioblastoma, a form of brain cancer, in preclinical animal models.
21 May 2008 : Lazaron Celling Itself Short Tuesday, May 20, 2008 @ 5:06PMMUCH vaunted stem cell specialist Lazaron, which currently operates an umbilical cord stem cell storage bank in the Western Cape, appears to be struggling to deliver promised profits.
Steelman, Hulshof push for pro-life votes in southwest Missouri Monday, May 19, 2008 @ 5:33PMBoth Republican candidates for governor are vying for conservative votes in the Republican primary election in August.
Hulshof pushes stem cell research Monday, May 19, 2008 @ 4:37PMRepublican gubernatorial candidate Kenny Hulshof was in Springfield today pushing stem cell research and use of umbilical cord blood.
Aldagen plans IPO worth up to $80.5 million Monday, May 12, 2008 @ 10:42AMA small Durham biotechnology company is planning to sell stock to the public to raise as much as $80.5 million, according to a filing with the Securities and Exchange Commission.
BioE to Participate in Launch of International Research Consortium on Cord Blood and Adult Stem Cells for Therapuetic ... Monday, May 12, 2008 @ 9:46AMBioE(R), Inc., a biomedical company that provides enabling, high-quality human stem cells for drug discovery and therapeutic research, announced today Gayl Chrysler, vice president of cellular technologies and clinical affairs for BioE, will participate in the launch of Novussanguis, an international research consortium on cord blood and adult stem cells for therapeutic applications, in Paris, ...
Father defends embryology Bill Monday, May 12, 2008 @ 8:54AMThe father of a British boy treated for a rare blood disorder with stem cells from a so-called "saviour sibling" has defended the controversial test tube procedure.
Aldagen, Inc. Files Registration Statement for Initial Public Offering Monday, May 12, 2008 @ 8:00AM Aldagen, Inc. today announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission relating to the proposed initial public offering of shares of its common stock.